DR. STUART HOLDEN

MDReal-Time Hydrated
Specialty: Urology
Practice Location: LOS ANGELES, CA 90095
NPI Number: 1013941483
LIFETIME INDUSTRY VALUE
$1,065,464
2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. HOLDEN is a verified Urology practitioner based in LOS ANGELES, CA.

Between 2021 and 2025, Dr. HOLDEN had an overall industry promotional and research financial footprint of $1,065,464 as recorded in the federal CMS Open Payments database.

  • $1,065,464 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. HOLDEN's primary funding source is UROGEN PHARMA, which accounts for $1,064,875 (representing 99.9% of overall industry footprint).

Data coverage: 2021 – 2025  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$397,337$198,669$0$195,1682021$127,0032022$188,0772023$157,8802024$397,3372025

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

UROGEN PHARMA
Rank 1
$1,064,875
99.9%
ROCHESTER MEDICAL CORPORATION
Rank 2
$378
0%
C. R. BARD, . & SUBSIDIARIES
Rank 3
$184
0%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Audit Trigger

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2025
2025
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.